{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:29:18Z","timestamp":1789194558748,"version":"build-2803163510"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,3]],"date-time":"2014-09-03T00:00:00Z","timestamp":1409702400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0105801","type":"journal-article","created":{"date-parts":[[2014,9,3]],"date-time":"2014-09-03T17:54:17Z","timestamp":1409766857000},"page":"e105801","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Calcium Channel Blockers and Risk of Breast Cancer: A Meta-Analysis of 17 Observational Studies"],"prefix":"10.1371","volume":"9","author":[{"given":"Wen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenggang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,9,3]]},"reference":[{"key":"ref1","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"R Siegel","year":"2012","journal-title":"CA: a cancer journal for clinicians"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMra1109345","article-title":"Noncommunicable diseases","volume":"369","author":"DJ Hunter","year":"2013","journal-title":"New England Journal of Medicine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1136\/bmj.311.7017.1391","article-title":"Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening","volume":"311","author":"M Quinn","year":"1995","journal-title":"Bmj"},{"key":"ref4","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"A Jemal","year":"2011","journal-title":"CA: a cancer journal for clinicians"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/jama.1996.03540100073032","article-title":"Calcium channel blockers","volume":"276","author":"AV Chobanian","year":"1996","journal-title":"JAMA: the journal of the American Medical Association"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/jama.1995.03530080036038","article-title":"The risk of myocardial infarction associated with antihypertensive drug therapies","volume":"274","author":"BM Psaty","year":"1995","journal-title":"JAMA: the journal of the American Medical Association"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF00314958","article-title":"Effect of the calcium antagonists nifedipine, nitrendipine, nimodipine and nisoldipine on oesophageal motility in man","volume":"41","author":"I Konrad-Dalhoff","year":"1991","journal-title":"European journal of clinical pharmacology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1532-5415.1994.tb06073.x","article-title":"Use of laxative medication in older persons and associations with low serum albumin","volume":"42","author":"M Pahor","year":"1994","journal-title":"Journal of the American Geriatrics Society"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/bmj.310.6982.776","article-title":"Surgical bleeding: unexpected effect of a calcium antagonist","volume":"310","author":"L Wagenknecht","year":"1995","journal-title":"BMJ: British Medical Journal"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0140-6736(96)90276-7","article-title":"Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old","volume":"347","author":"M Pahor","year":"1996","journal-title":"The Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF01974690","article-title":"Effects of calcium channel blockers on the development of early rat postimplantation embryos in culture","volume":"64","author":"G Stein","year":"1990","journal-title":"Archives of toxicology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0140-6736(93)91154-E","article-title":"Apoptosis and disease","volume":"341","author":"DA Carson","year":"1993","journal-title":"The Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(96)04277-8","article-title":"Calcium-channel blockade and incidence of cancer in aged populations","volume":"348","author":"M Pahor","year":"1996","journal-title":"The Lancet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/cncr.11663","article-title":"Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65\u201379 years","volume":"98","author":"CI Li","year":"2003","journal-title":"Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004872-199816010-00017","article-title":"Cancer risk of hypertensive patients taking calcium antagonists","volume":"16","author":"DJ Hole","year":"1998","journal-title":"Journal of hypertension"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8<1438::AID-CNCR11>3.0.CO;2-6","article-title":"Use of calcium channel blockers and breast carcinoma risk in postmenopausal women","volume":"80","author":"AL Fitzpatrick","year":"1997","journal-title":"Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jamainternmed.2013.9071","article-title":"Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years","volume":"173","author":"CI Li","year":"2013","journal-title":"JAMA internal medicine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archinte.160.3.349","article-title":"Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer","volume":"160","author":"CR Meier","year":"2000","journal-title":"Archives of internal medicine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/1097-0142(20000701)89:1<165::AID-CNCR21>3.0.CO;2-G","article-title":"Cancer risk and mortality in users of calcium channel blockers","volume":"89","author":"HT S\u00f8rensen","year":"2000","journal-title":"Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/(SICI)1097-0142(19981101)83:9<2003::AID-CNCR17>3.0.CO;2-3","article-title":"Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of US women","volume":"83","author":"KB Michels","year":"1998","journal-title":"Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jama.279.13.1000","article-title":"Calcium channel blockers and the risk of cancer","volume":"279","author":"L Rosenberg","year":"1998","journal-title":"JAMA: The Journal of the American Medical Association"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(97)80084-0","article-title":"Calcium-channel blockers and risk of cancer","volume":"349","author":"H Jick","year":"1997","journal-title":"The Lancet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.HYP.29.5.1091","article-title":"Cancer risk in users of calcium channel blockers","volume":"29","author":"JH Olsen","year":"1997","journal-title":"Hypertension"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcms.2010.11.001","article-title":"Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias","volume":"39","author":"K Knobloch","year":"2011","journal-title":"Journal of Cranio-Maxillofacial Surgery"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"D Moher","year":"2009","journal-title":"Annals of internal medicine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997","journal-title":"Bmj"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1002\/sim.2889","article-title":"Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity","volume":"26","author":"JL Peters","year":"2007","journal-title":"Statistics in medicine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and Fill: A Simple Funnel-Plot\u2013Based Method of Testing and Adjusting for Publication Bias in Meta-Analysis","volume":"56","author":"S Duval","year":"2000","journal-title":"Biometrics"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/pds.910","article-title":"Breast cancer incidence and use of antihypertensive medication in women","volume":"13","author":"A Gonzalez-Perez","year":"2004","journal-title":"Pharmacoepidemiology and drug safety"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10549-005-9091-x","article-title":"A cohort study of antihypertensive medication use and breast cancer among Danish women","volume":"97","author":"JP Fryzek","year":"2006","journal-title":"Breast cancer research and treatment"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10654-007-9135-0","article-title":"Medication use and the risk of breast cancer","volume":"22","author":"S Davis","year":"2007","journal-title":"European journal of epidemiology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/pds.1656","article-title":"Long-term use of antihypertensive drugs and risk of cancer","volume":"17","author":"TL Assimes","year":"2008","journal-title":"Pharmacoepidemiology and drug safety"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10552-012-0122-8","article-title":"Use of antihypertensive medications and breast cancer risk","volume":"24","author":"BS Saltzman","year":"2013","journal-title":"Cancer Causes & Control"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.canep.2013.09.001","article-title":"Antihypertensive medications and survival in patients with cancer: A population-based retrospective cohort study","volume":"37","author":"S Holmes","year":"2013","journal-title":"Cancer epidemiology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0959-8049(02)00157-0","article-title":"Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study","volume":"39","author":"A Beiderbeck-Noll","year":"2003","journal-title":"European Journal of Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0735-1097(98)00008-4","article-title":"Calcium Channel Blocking Agents and Risk of Cancer in Patients With Coronary Heart Disease 1","volume":"31","author":"S Braun","year":"1998","journal-title":"Journal of the American College of Cardiology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/pds.737","article-title":"Use of calcium channel blockers as antihypertensives in relation to mortality and cancer incidence: a population-based observational study","volume":"11","author":"G Lindberg","year":"2002","journal-title":"pharmacoepidemiology and drug safety"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jss.2012.04.027","article-title":"Pterostilbene induces mitochondrially derived apoptosis in breast cancer cells <italic>in vitro<\/italic>","volume":"180","author":"D Moon","year":"2013","journal-title":"Journal of Surgical Research"},{"key":"ref39","article-title":"Selaginella Active Fractions Induce Apoptosis on T47D Breast Cancer Cell","volume":"23","author":"S Handayani","year":"2013","journal-title":"Indonesian Journal of Pharmacy"},{"key":"ref40","article-title":"Mitochondrial calcium uniporter silencing potentiates caspase-independent cell death in MDA-MB-231 breast cancer cells","author":"MC Curry","year":"2013","journal-title":"Biochemical and biophysical research communications"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/pcmr.12155","article-title":"T-type calcium channel blockers inhibit autophagy and promote apoptosis of malignant melanoma cells","volume":"26","author":"A Das","year":"2013","journal-title":"Pigment cell & melanoma research"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1016\/j.bmcl.2013.10.049","article-title":"In vitro cytotoxicity on human ovarian cancer cells by T-type calcium channel blockers","volume":"23","author":"SJ Jang","year":"2013","journal-title":"Bioorganic & medicinal chemistry letters"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e81222","DOI":"10.1371\/journal.pone.0081222","article-title":"Nifedipine treatment reduces resting calcium concentration, oxidative and apoptotic gene expression, and improves muscle function in dystrophic mdx mice","volume":"8","author":"F Altamirano","year":"2013","journal-title":"PloS one"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0198220","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"record-id":"18284"},{"DOI":"10.1371\/journal.pone.0198220","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0105801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T03:11:57Z","timestamp":1588993917000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0105801"}},"subtitle":[],"editor":[{"given":"Rodney John","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,3]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0105801","relation":{"retraction":[{"id-type":"doi","id":"10.1371\/journal.pone.0198220","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,3]]}}}